| Sr No | Product Name | CAS NO | End Use |
|---|---|---|---|
| 1 | 2 Mercapto Benzimidazole | 583-39-1 | Lansoprazole and Rabeprazole |
| 2 | Zinc salt of 2 Mercapto Benzimidazole | 3030-80-6 | Rubber chemicals |
| 3 | 5 Amino 2 Mercapto Benzimidazole | 2818-66-6 | Ilaprazole |
| 4 | 5- 1 H- Pyrol 1Yl -2 Mercapto Benzimidazole | 1721252-53-3 | Ilaprazole |
| 5 | 5 Nitro Benzimidazole | 94-52-0 | Antifogging agent |
| 6 | 4 Nitro Ortho Phenylene Diamine | 99-56-9 | Ilaprazole |
| 7 | 4 Methylamino Phenol Sulfate ( METOL) | 55-55-0 | Photographic chemical |
| 8 | Benzimidazole | 51-17-2 | Antihelmintics |
| 9 | 5 Chloro Benzimidazole | 4887-82-5 | Antihelmintics |
| 10 | 2 Methyl BENZIMIDAZOLE | 615-15-6 | Synthesis of various antibacterial and antifungal agents |
| 11 | 5 Nitro Benzimidazole Nitrate | 27896-84-0 | Manufacturing of photosensitive materials |
| 12 | 4 Chloro Ortho Phenylene Diamine | 95-83-0 | Synthesis of dyes and experimental pharmaceuticals |
| 13 | 5 Chloro Benzotriazole | 94-97-3 | Corrosion inhibitor for copper and its alloys |
| 14 | 4/5 Methyl 2 Mercapto Benzimidazole | 53988-10-6 | Rubber chemicals |
| 15 | Zinc salt of 4/5 Methyl 2 2 Mercapto Benzimidazole | 61617-00-3 | Rubber chemicals |
| 16 | 2 Mercapto Benzoxazole | 2382-96-9 | Lansoprazole and Rabeprazole |
| 17 | 5 Nitro Benzotriazole | (2338-12-7) | Synthesis of cephalosporins |
| 18 | 2 Chloro Benzoxazole | 615-18-9 | Synthetic intermediate |
| 19 | 5 Chloro 2 Mercapto Benzoxazole | 22876-19-3 | Antibacterial agent |
| 20 | Tezacaftor | 1152311-62-0 | Tezacaftor |
| 21 | (2R)-1-{5-amino-2-[1-(benzyloxy)-2-methyl-2-propanyl]-6-fluoro-1H-indol-1-yl}-3-(benzyloxy)-2-propanol | 1294504-67-8 | Tezacaftor |
| 22 | 1-(2,2-difluorobenzo[1,3]dioxol-5-yl)cyclopropane-1-carboxylic acid | 862574-88-7 | Tezacaftor |
| 23 | 2-Bromo-5-fluoro-4-nitroaniline | 952664-69-6 | Tezacaftor |
| 24 | Tapinarof | 79338-84-4 | Tapinarof |
| 25 | Phosphonic acid, [[3,5-dimethoxy-4-(1-methylethyl)phenyl]methyl]-, diethyl ester (9CI) | 443982-76-1 | Tapinarof |
| 26 | (4-Isopropyl-3,5-dimethoxyphenyl)methanol | 344396-18-5 | Tapinarof |
| 27 | 5-(4-Bromophenyl)-6-hydroxypyrimidin-4(1H)-one | 706811-25-8 | Macitentan intermediate |
| 28 | 5-(4-bromophenyl)-4,6-dichloropyriMidine | 146533-41-7 | Macitentan intermediate |
| 29 | Benzonitrile, 5-[3-(2,3-dihydro-1-oxo-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)- | 2251699-84-8 | Ozanimod hydrochloride |
| 30 | Ozanimod hydrochloride | 1618636-37-5 | Ozanimod hydrochloride |
| 31 | Propanedioic acid, 2-[(2-bromophenyl)methyl]- | 58380-12-4 | Ozanimod hydrochloride |
| 32 | Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)aMino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-Methylethoxy)- (HCl salt) | 1306760-85-9 | Ozanimod hydrochloride |
| 33 | (R)-tert-Butyl(4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | 1306763-30-3 | Ozanimod hydrochloride |
| 34 | (S)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrilehydrochloride | 1306763-57-4 | Ozanimod hydrochloride |
| 35 | 2,3-dihydro-1-oxo-1H-indene-4-carbonitrile | 60899-34-5 | Ozanimod hydrochloride |
| 36 | 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid | 2212021-83-3 | Orforglipron |
| 37 | (S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride | 2212022-57-4 | Orforglipron |
| 38 | tert-butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212021-61-7 | Orforglipron |
| 39 | (S)-oxetan-2-ylmethanamine | 2091328-57-1 | Danuglipron (GLP-1) |
| 40 | (R)-oxetan-2-ylmethanamine | 2090728-35-9 | Danuglipron (GLP-1) |
| 41 | (S)-oxetan-2-ylmethanamine 4-methylbenzenesulfonate | 2740593-38-6 | Danuglipron (GLP-1) |
| 42 | Methyl (S)-2-(Chloromethyl)-1-(2-oxetanylmethyl)-1H-benzo[d]imidazole-6-carboxylate | 2230200-76-5 | Danuglipron (GLP-1) |
| 43 | Pralsetinib | 2097132-94-8 | Pralsetinib |
| 44 | 3-Pyridinemethanamine, 6-(4-fluoro-1H-pyrazol-1-yl)-α-methyl-, (αR)- | 2054317-97-2 | Pralsetinib |
| 45 | Methyl 4-(4-chloro-6-methylpyrimidin-2-yl)-1-methoxyclohexanecarboxylate | 2097133-31-6 | Pralsetinib |
| 46 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine | 1980023-96-8 | Pralsetinib |
| 47 | 6-CHLORO-3-INDOXYL-BETA-D-GLUCOPYRANOSIDE TRIHYDRATE | 2097133-32-7 | Pralsetinib |
| 48 | methyl 1-methoxy-4-(4-methyl-6-(methylsulfonyl)pyrimidin-2-yl)cyclohexane-1-carboxylate | 2097133-29-2 | Pralsetinib |
| 49 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride | 1980023-97-9 | Pralsetinib |
| 50 | Siponimod hemi-fumarate | 1234627-85-0 | BAF-312(Siponimod) |
| 51 | BAF-312(SiponiMod) | 1230487-00-9 | BAF-312(Siponimod) |
| 52 | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethan-1-one | 1378888-43-7 | BAF-312(Siponimod) |
| 53 | Ethanone, 1-[3-ethyl-4-(hydroxymethyl)phenyl]-,O-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methyl]oxime, (1E)- | 1418144-66-7 | BAF-312(Siponimod) |
| 54 | Benzene, 4-(bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)- | 800381-60-6 | BAF-312(Siponimod) |
| 55 | Benzene, 4-(chloromethyl)-1-cyclohexyl-2-(trifluoromethyl)- | 957205-24-2 | BAF-312(Siponimod) |
| 56 | Iptacopan | 1644670-37-0 | Iptacopan |
| 57 | (-)-(2S,4S)-benzyl 2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate | 1644667-56-0 | Iptacopan |
| 58 | methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate | 1644667-62-8 | Iptacopan |
| 59 | (2S,4S)-4-ethoxy-2-(4-methoxycarbonylphenyl)-1-piperidinecarboxylic acid (phenylmethyl) ester | 1644667-60-6 | Iptacopan |
| 60 | benzyl (S)-2-(4-(methoxycarbonyl)phenyl)-4-oxopiperidine-1-carboxylate | 2408761-20-4 | Iptacopan |
| 61 | benzyl (2S,4S)-4-hydroxy-2-(4-methoxycarbonylphenyl)piperidine-1-carboxylate | 2408761-17-9 | Iptacopan |
| 62 | tert-butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate | 1481631-51-9 | Iptacopan |
| 63 | Etrasimod | 1206123-37-6 | Etrasimod |
| 64 | 4-(Chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene | 957208-65-0 | Etrasimod |
| 65 | Ethyl 2-{7-hydroxy-1H,2H,3H,4H-cyclopenta[b]indol-3-yl}acetate | 1206124-13-1 | Etrasimod |
| 66 | methyl 4-cyclopentyl-3-(trifluoromethyl)benzoate | 161622-16-8 | Etrasimod |
| 67 | Cyclopent[b]indole-3-acetic acid, 3-(ethoxycarbonyl)-1,2,3,4-tetrahydro-7-methoxy-, ethyl ester | 1206125-20-3 | Etrasimod |
| 68 | Delafloxacin meglumine | 352458-37-8 | Delafloxacin meglumine |
| 69 | 3,5-Difluoropyridine-2,6-diamine | 247069-27-8 | Delafloxacin meglumine |
| 70 | 3-Quinolinecarboxylic acid, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6,7-difluoro-1,4-dihydro-4-oxo-, ethyl ester | 189279-51-4 | Delafloxacin meglumine |
| 71 | (R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole | 143322-57-0 | Eletriptan intermediate |
| 72 | Rotigotine | 99755-59-6 | Rotigotine |
| 73 | (S)-2-Amino-5-methoxytetralin (S)-mandelate | 439133-67-2 | Rotigotine |
| 74 | (S)-6-(Propylamino)-5,6,7,8-tetrahydronaphthalen-1-olhydrobromide | 165950-84-5 | Rotigotine |
| 75 | (S)-1,2,3,4-tetrahydro-5-Methoxy-N-propyl-2-NaphthalenaMine(Rotigotine) | 101403-24-1 | Rotigotine |
| 76 | Lefamulin Acetate | 1350636-82-6 | Lefamulin Acetate |
| 77 | tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate | 1350636-75-7 | Lefamulin Acetate |
| 78 | tert-butyl N-[(1R,3R,4R)-4-(benzoylsulfanyl)-3-hydroxycyclohexyl]carbamate | 1350636-89-3 | Lefamulin Acetate |
| 79 | Mirogabalin besylate | 1138245-21-2 | Mirogabalin besylate |
| 80 | (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one | 1235479-61-4 | Mirogabalin besylate |
| 81 | 3-ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-59-0 | Mirogabalin besylate |
| 82 | Linzagolix choline | 1321816-57-2 | Linzagolix choline |
| 83 | Linzagolix | 935283-04-8 | Linzagolix |
| 84 | 2,3-Thiophenedicarboxylic acid, 4-[[[[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]amino]carbonyl]amino]-, 2,3-dimethyl ester | 1581731-16-9 | Linzagolix |
| 85 | Benzenamine, 5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxy- | 935287-59-5 | Linzagolix |
| 86 | Benzene, 1,2-difluoro-3-[(4-fluoro-2-methoxy-5-nitrophenoxy)methyl]-4-methoxy- | 1073435-71-8 | Linzagolix |
| 87 | 2,3-Difluoro-6-methoxybenzaldehyde | 187543-87-9 | Linzagolix |
| 88 | 2,3-Difluoro-6-methoxybenzyl alcohol | 773871-99-1 | Linzagolix |
| 89 | Dimethyl 4-aminothiophene-2,3-dicarboxylate hydrochloride | 121071-71-4 | Linzagolix |
| 90 | Milvexian | 1073371-77-3 | Milvexian |
| 91 | 4-(5-chloro-2-(4-(trimethylsilyl)-1H-1,2,3-triazol-1-yl)phenyl)-6-methoxypyrimidine | 1802430-53-0 | Milvexian |
| 92 | Pyrimidine, 4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-methoxy- | 1802430-54-1 | Milvexian |
| 93 | 4-Chloro-2-(6-methoxypyrimidin-4-yl)aniline | 1802430-18-9 | Milvexian |
| 94 | 6-(5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl)pyrimidin-4-ol | 1802430-55-2 | Milvexian |
| 95 | tert-butyl ((5R,9S)-21-(difluoromethyl)-5-methy1.4-oxo-21H-3-aza-1(4,2)-pyridina-2(5,4)-pyrazolacyclononaphane-9-yl)carbamate | 1802431-23-7 | Milvexian |
| 96 | zavegepant HCl | 1414976-20-7 | zavegepant HCl |
| 97 | methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate dihydrochloride | 1414976-14-9 | zavegepant HCl |
| 98 | 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride | 855778-84-6 | zavegepant HCl |
| 99 | 1-(1-METHYLPIPERIDIN-4-YL)PIPERAZINE 3HCL | 349535-15-5 | zavegepant HCl |
bd@globelapharma.com
Copyright © 2024 Globela Pharma. All rights reserved.